Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity

Annals of Oncology

Volumn 16, Issue 5, 2005, Pages 767-772

  Lemmens, V E P P ^a,e   van Halteren, A H ^b   Janssen Heijnen, M L G ^a   Vreugdenhil, G ^c   Repelaer van Driel, O J ^c   Coebergh, J W W ^a,d  

^a The Netherlands   (Netherlands)

^b Oosterschelde Hospital   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e IKZ   (Netherlands)

Author keywords

Adjuvant chemotherapy; Cancer registry; Colon cancer; Elderly; Survival

Indexed keywords

FLUOROURACIL;

AGED; AGING; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON RESECTION; COLORECTAL CANCER; COMORBIDITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NETHERLANDS; PRIORITY JOURNAL; RECTUM RESECTION; SEX DIFFERENCE; SOCIAL STATUS; SOCIOECONOMICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; COMORBIDITY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM STAGING; NETHERLANDS; ODDS RATIO; PROBABILITY; PROGNOSIS; REGISTRIES; RISK ASSESSMENT; SEX FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20044370090     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdi159     Document Type: Article

References (32)

1. Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ et al. Cancer incidence and survival in the South of the Netherlands, 1955-1999 & incidence in the North of Belgium, 1996-1998 [CD-ROM]. Eindhoven: Comprehensive Cancer Centre South (IKZ) 2001.
2. O'Connell MJ, Mailliard JA, Kahn MJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15: 246-250.
3. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444-1450.
4. Moertel CG, Fleming TR, Macdonald JS et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-358.
5. Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004; 22: 1797-1806.
6. Sargent DJ, Goldberg RM, Jacobson SD et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345: 1091-1097.
7. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002; 20: 3992-3998.
8. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93: 850-857.
9. Ayanian JZ, Zaslavsky AM, Fuchs CS et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003; 21: 1293-1300.
10. Oncoline: oncologic, guidelines. Utrecht: VIKC 2004. Available from URL: http://www.oncoline.nl (1 Aug 2004, date last accessed).
11. Schouten LJ, Hoppener P, van den Brandt PA et al. Completeness of cancer registration in Limburg. The Netherlands. Int J Epidemiol 1993; 22: 369-376.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
13. UICC. TNM Classification of Malignant Tumours. Sixth edition. New York: Wiley-Liss 2002; 75.
14. de Rijke JM, Schouten LJ, Schouten HC et al. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg. The Netherlands. Ann Oncol 1996; 7: 677-685.
15. Bouchardy C, Queneau PE, Fioretta G et al. Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice. Br J Cancer 2001; 85: 1251-1257.
16. Sundararajan V, Grann VR, Jacobson JS et al. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J 2001; 7: 213-218.
17. Potosky AL, Harlan LC, Kaplan RS et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 2002; 20: 1192-1202.
18. Kohne CH, Grothey A, Bokemeyer C et al. Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 2001; 12: 435-442.
19. Biganzoli L, Aapro M. Adjuvant chemotherapy in the elderly. Ann Oncol 2003; 14 (Suppl 3): iii1-iii3.
20. Repetto L, Venturino A, Fratino L et al. Geriatric oncology. a clinical approach to the older patient with cancer. Eur J Cancer 2003; 39: 870-880.
21. Sundararajan V, Mitra N, Jacobson JS et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002; 136: 349-357.
22. Sloan JA, Goldberg RM, Sargent DJ et al. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol 2002; 20: 1491-1498.
23. Patel K, Anthoney DA, Crellin AM et al. Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection. Ann Oncol 2004; 15: 568-573.
24. International Publication Series Health, Welfare and Sport no. 1E: Health Insurance in the Netherlands. The Hague: Ministry of Health, Welfare and Sport 2004. Available from URL: http://www.minvws.nl/images/ Health%20Insurance%20in%20the%20Netherlands_tcm11-53018.pdf (1 Aug 2004, date last accessed).
25. Franks P, Gold MR, Fiscella K. Sociodemographics, self-rated health, and mortality in the US. Soc Sci Med 2003; 56: 2505-2514.
26. van der Meer JB, Mackenbach JP. Course of health status among chronically ill persons: differentials according to level of education. J Clin Epidemiol 1998; 51: 171-179.
27. Neugut AI, Fleischauer AT, Sundararajan V et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 2002; 20: 2643-2650.
28. Le Voyer TE, Sigurdson ER, Hanlon AL et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21: 2912-2919.
29. Fata F, Mirza A, Craig G et al. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer 2002; 94: 1931-1938.
30. Satariano WA. Comorbidities and cancer. In Hunter CP, Johnson KA, Muss HB (eds): Cancer in the elderly. New York, NY: Marcel Dekker Inc. 2000; 477-499.
31. Repetto L, Fratino L, Audisio RA et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002; 20: 494-502.
32. Extermann M, Overcash J, Lyman GH et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16: 1582-1587.